Viewing Study NCT01401868


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-02-22 @ 12:08 AM
Study NCT ID: NCT01401868
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2011-07-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Sponsor: MEI Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None solid tumor View
None recurrent View
None advanced View